Fulgent Genetics
FLGT
37 hedge funds and large institutions have $35.5M invested in Fulgent Genetics in 2016 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 3 closing their positions.
733% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 3
147% more funds holding
Funds holding: 15 → 37 (+22)
45% more capital invested
Capital invested by funds: $24.4M → $35.5M (+$11.1M)
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
17.35% more ownership
Funds ownership: 0% → 17.35% (+17%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.15M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$1.9M |
| 3 |
SC
Scholtz & Company
Stamford,
Connecticut
|
+$1.68M |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$725K |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$544K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$738K |
| 2 |
Millennium Management
New York
|
-$616K |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$451K |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$92K |
| 5 |
PHK
Point72 Hong Kong
Hong Kong
|
-$66K |
FLGT Hedge Fund Activity: Q4 2016 in Review
37 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q4 2016, worth a combined $35.5M — up 45% from $24.4M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new FLGT positions and 3 closed out — a net gain of 22 holders — while 4 added to existing stakes and 3 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $2.15M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $738K sold.
- 37 institutional investors held Fulgent Genetics (FLGT) as of Q4 2016, up from 15 in Q3 2016.
- Funds reported $35.5M of Fulgent Genetics stock for Q4 2016, up 45% quarter-over-quarter.
- 25 funds opened new Fulgent Genetics positions in Q4 2016 and 3 closed out, a net change of +22 holders.
- The largest Fulgent Genetics buyer in Q4 2016 was Vanguard Group, an estimated $2.15M added.
- The largest Fulgent Genetics seller in Q4 2016 was Point72 Asset Management, an estimated $738K sold.
Based on aggregated 13F filings for Q4 2016.